These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33075684)

  • 21. Efficacy and safety comparison of neoadjuvant chemotherapy followed by surgery and upfront surgery for treating intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
    Yang Z; Jiang X
    BMC Gastroenterol; 2023 Apr; 23(1):122. PubMed ID: 37046191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma.
    Sumiyoshi T; Shima Y; Okabayashi T; Negoro Y; Shimada Y; Iwata J; Matsumoto M; Hata Y; Noda Y; Sui K; Sueda T
    World J Surg; 2018 Sep; 42(9):2910-2918. PubMed ID: 29511872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
    Kunzmann V; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens U; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Klein I; Germer CT; Stein H; Friess H; Bahra M; Jakobs R; Hartlapp I; Heinemann V;
    Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):128-138. PubMed ID: 33338442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma.
    Franssen S; Holster JJ; Jolissaint JS; Nooijen LE; Cercek A; D'Angelica MI; Homs MYV; Wei AC; Balachandran VP; Drebin JA; Harding JJ; Kemeny NE; Kingham TP; Klümpen HJ; Mostert B; Swijnenburg RJ; Soares KC; Jarnagin WR; Groot Koerkamp B
    Ann Surg Oncol; 2024 Jan; 31(1):115-124. PubMed ID: 37814188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete response of recurrent perihilar cholangiocarcinoma following sintilimab combined with lenvatinib plus S-1: a case report and review of literature.
    Liu QQ; Yu XH; Tang QB; Chen D; Zhang R; Liu C; Shi XD
    Anticancer Drugs; 2024 Jan; 35(1):81-85. PubMed ID: 37227031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
    Edeline J; Touchefeu Y; Guiu B; Farge O; Tougeron D; Baumgaertner I; Ayav A; Campillo-Gimenez B; Beuzit L; Pracht M; Lièvre A; Le Sourd S; Boudjema K; Rolland Y; Boucher E; Garin E
    JAMA Oncol; 2020 Jan; 6(1):51-59. PubMed ID: 31670746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease.
    van Keulen AM; Buettner S; Olthof PB; Klümpen HJ; Erdmann JI; Izquierdo-Sanchez L; Banales JM; Goeppert B; Roessler S; Zieniewicz K; Lamarca A; Valle JW; La Casta A; Hoogwater FJH; Donadon M; Scheiter A; Marzioni M; Adeva J; Kiudeliene E; Fernández JMU; Vidili G; Mocan T; Fabris L; Krawczyk M; Folseraas T; Dopazo C; Detry O; Voiosu T; Scripcariu V; Biancaniello F; Braconi C; Macias RIR; Groot Koerkamp B
    Ann Surg Oncol; 2024 Oct; 31(10):6495-6503. PubMed ID: 38896226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis.
    Tang Z; Yang Y; Zhao Z; Wei K; Meng W; Li X
    Medicine (Baltimore); 2018 Aug; 97(34):e11999. PubMed ID: 30142840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.
    Lunsford KE; Javle M; Heyne K; Shroff RT; Abdel-Wahab R; Gupta N; Mobley CM; Saharia A; Victor DW; Nguyen DT; Graviss EA; Kaseb AO; McFadden RS; Aloia TA; Conrad C; Li XC; Monsour HP; Gaber AO; Vauthey JN; Ghobrial RM;
    Lancet Gastroenterol Hepatol; 2018 May; 3(5):337-348. PubMed ID: 29548617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical feasibility of curative surgery after nab-paclitaxel plus gemcitabine-cisplatin chemotherapy in patients with locally advanced cholangiocarcinoma.
    Choi SH; Kang I; Lee SH; Kang B; Cheon J; Kim DJ; Kim G; Kwon CI; Ko KH; Chon HJ
    Surgery; 2023 Feb; 173(2):280-288. PubMed ID: 36435652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin.
    Huh G; Ryu JK; Chun JW; Kim JS; Park N; Cho IR; Paik WH; Lee SH; Kim YT
    BMC Cancer; 2020 Sep; 20(1):907. PubMed ID: 32967632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years.
    Pracht M; Le Roux G; Sulpice L; Mesbah H; Manfredi S; Audrain O; Boudjema K; Raoul JL; Boucher E
    Chemotherapy; 2012; 58(2):134-41. PubMed ID: 22572213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of unresectable locally advanced intrahepatic cholangiocarcinoma that achieved pathological complete response after gemcitabine and S1 chemotherapy.
    Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Otsuka H; Serikawa M; Ishii Y; Tsuboi T; Arihiro K; Takahashi S
    Clin J Gastroenterol; 2022 Dec; 15(6):1164-1168. PubMed ID: 36181621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does additional resection of a positive microscopic ductal margin benefit patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis.
    Ke Q; Chen Y; Huang Q; Lin N; Wang L; Liu J
    PLoS One; 2020; 15(5):e0232590. PubMed ID: 32379819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
    Sahai V; Catalano PJ; Zalupski MM; Lubner SJ; Menge MR; Nimeiri HS; Munshi HG; Benson AB; O'Dwyer PJ
    JAMA Oncol; 2018 Dec; 4(12):1707-1712. PubMed ID: 30178032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repetitive response to gemcitabine that led to curative resection in cholangiocarcinoma.
    Kim SH; Kim IH; Kim SW; Lee SO
    World J Gastroenterol; 2009 Sep; 15(36):4593-5. PubMed ID: 19777621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma.
    Matsuyama R; Mori R; Ota Y; Homma Y; Yabusita Y; Hiratani S; Murakami T; Sawada Y; Miyake K; Shimizu Y; Kumamoto T; Endo I
    Ann Surg Oncol; 2022 Apr; 29(4):2393-2405. PubMed ID: 34994885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incremental value of volumetric multiparametric MRI over Fudan score for prognosis of unresectable intrahepatic cholangiocarcinoma treated with systemic chemotherapy.
    Pandey A; Mohseni A; Shaghaghi M; Pandey P; Rezvani Habibabadi R; Hazhirkarzar B; Ly A; Panid Madani S; Borhani A; Kamel IR
    Eur J Radiol; 2024 Jan; 170():111196. PubMed ID: 38029705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival.
    Marquardt S; Kirstein MM; Brüning R; Zeile M; Ferrucci PF; Prevoo W; Radeleff B; Trillaud H; Tselikas L; Vicente E; Wiggermann P; Manns MP; Vogel A; Wacker FK
    Eur Radiol; 2019 Apr; 29(4):1882-1892. PubMed ID: 30255257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.